Omeros Corp (NASDAQ:OMER)

22.79
Data as of Dec 26
 +0.70 / +3.17%
Today’s Change
9.76
Today|||52-Week Range
23.63
+101.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$752.7M

Company Description

Omeros Corp. is a clinical stage biopharmaceutical company, which engages in the discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. Its products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. The company also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. Omeros was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Contact Information

Omeros Corp.
201 Elliott Avenue West
Seattle Washington 98119
P:(206) 676-5000
Investor Relations:

Employees

Shareholders

Individual stakeholders8.41%
Other institutional26.07%
Mutual fund holders16.09%

Top Executives

Gregory A. DemopulosChairman, President & Chief Executive Officer
David R. TollSenior Director-Finance
Michael A. JacobsenChief Financial Officer, Treasurer, CAO & VP
George A. GaitanarisChief Scientific Officer & Vice President
J. Steven WhitakerChief Medical Officer & VP-Clinical Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.